Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03610061
Title A Trial of Radiotherapy and Durvalumab in DLBCL and FL (RaDD)
Acronym RaDD
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Austin Health
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.